Nikolaj Falstie-Jensen, CTO at Miiskin

Nikolaj Falstie-Jensen is the Co-Founder and Chief Technology Officer of Miiskin, a digital health company focused on expanding access to dermatology care through innovative technology. Since co-founding Miiskin in 2015, he has led the company’s technology strategy and product development, helping transform Miiskin from a skin monitoring application into a comprehensive digital dermatology platform serving patients and healthcare providers across the United States.
With a background in software engineering and digital product development, Nikolaj is passionate about building scalable healthcare technology that simplifies complex clinical workflows while maintaining high standards for security, reliability, and user experience. He has played a central role in architecting Miiskin’s patient and provider platforms, enabling dermatologists to deliver care more efficiently through digital-first workflows, structured patient data collection, and teledermatology solutions.
Nikolaj believes that technology should remove friction from healthcare rather than add to it. His work focuses on creating intuitive systems that empower both patients and clinicians, ensuring that digital healthcare experiences are accessible, secure, and clinically effective. He is particularly interested in the application of cloud technologies, automation, and artificial intelligence to improve operational efficiency and support healthcare professionals in delivering better patient outcomes.
As AI continues to reshape healthcare, Nikolaj advocates for practical and responsible implementations that augment clinical expertise rather than replace it. His focus is on leveraging AI to streamline administrative processes, improve platform intelligence, strengthen quality assurance, and enhance patient engagement while preserving transparency, privacy, and medical oversight. Through his leadership, Miiskin continues to develop technology that helps make dermatology care more accessible, efficient, and scalable for the future.
